A Study of WVT078 in Patients With Multiple Myeloma (MM)

Clinical trial NCT04123418 · TERMINATED

Trial details

NCT number: NCT04123418
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma (MM)

Start date: 2019-12-05
Primary completion: 2024-12-02
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.